As TLR4 is expressed on both macrophages and DC, we questioned whether IVIg or the CD44 antibody KM114 might utilize the TLR4 pathway in its amelioration of immune thrombocytopenia. The gene discussed is CD44; the disease is autoimmune thrombocytopenic purpura.